Evaluating the Effectiveness of Nutraceuticals as Supportive Therapies in Cancer Treatment

P, Sharma, Subbappa, Priya Ak, Mr and S

Health Leadership and Quality of Life, 2025, vol. 4, 605

Abstract: Cancer treatment has changed over the years, with a move toward more specialized therapies. Nutraceuticals are now used along with traditional therapies like chemotherapy, radiotherapy, and immunotherapy to help the body fight cancer. Nutraceuticals are beneficial substances that come from food. They are getting more attention because they might be able to change how cells work, boost the immune system, and lessen the bad effects of cancer treatments. The point of this study is to find out how well nutraceuticals work as supporting medicines in cancer treatment, with a focus on how they might help improve treatment results, lower side effects, and raise quality of life. A growing amount of study shows that nutraceuticals like antioxidants, flavonoids, omega-3 fatty acids, and some vitamins may help by focusing on chemical processes that help cancer cells grow, die, and spread. A number of studies have shown that these chemicals can make cancer cells more sensitive to chemotherapy and radiotherapy, which could make these treatments more effective overall. Additionally, some nutraceuticals have anti-inflammatory, anti-oxidant, and immunomodulatory qualities that may help patients deal with side effects of their treatment, such as pain, sickness, tiredness, and a weakened immune system. This review brings together the results of both clinical and lab studies that looked into the role of nutraceuticals in breast, prostate, lung, and colon cancers, among others. We look at the data that supports their use in making chemotherapy and radiotherapy work better, lowering the risk of tumors coming back, and making patient results better. There are still problems, like the fact that product quality and dose schedules vary and that there needs to be a clear set of professional rules.

Date: 2025
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:health:v:4:y:2025:i::p:605:id:605

DOI: 10.56294/hl2025605

Access Statistics for this article

More articles in Health Leadership and Quality of Life from AG Editor
Bibliographic data for series maintained by Javier Gonzalez-Argote ().